Conference Coverage
Lipid Metabolism May Be a Therapeutic Target in MS
NASHVILLE—Multiple sclerosis (MS) traditionally has been considered a chronic inflammatory autoimmune disease, but...
Conference Coverage
Ozanimod May Provide Better MS Outcomes Than Interferon Beta
NASHVILLE—Two doses of ozanimod provide greater benefits on annualized relapse rate and MRI end points than interferon beta-1a...
Conference Coverage
CMSC Guideline Re-Examines Use of Gadolinium-Based Contrast Agents
NASHVILLE—Gadolinium-based contrast agents (GBCAs) are necessary for the accurate initial diagnosis of patients experiencing a...
Conference Coverage
Eating Fish May Be Associated With a Reduced Risk of MS
LOS ANGELES—Eating fish at least once per week or eating fish one to three times per month, in addition to taking daily fish oil...
Conference Coverage
High-Intensity Interval Exercise May Be Appropriate for Patients With MS
NASHVILLE—For patients with multiple sclerosis (MS) and walking impairments, high-intensity interval exercise is as enjoyable as...
Conference Coverage
Reducing the Risk of PML During MS Treatment
NASHVILLE—For patients with multiple sclerosis (MS) who receive treatment with natalizumab, progressive multifocal...
Video
John DeLuca, PhD
At the 2018 CMSC Annual Meeting, Dr. DeLuca discusses the role of cognitive rehabilitation in MS.
Conference Coverage
What Are Predictors of Mortality in Veterans With MS?
NASHVILLE—Among veterans with multiple sclerosis (MS), excess MS-related mortality is mainly influenced...
Conference Coverage
Cladribine Tablets Improve MRI Outcomes in Patients With Highly Active Relapsing-Remitting MS
NASHVILLE—Treatment with cladribine tablets 3.5 mg/kg reduces MRI markers of disease activity in patients with highly active...
Conference Coverage
Compared With Interferon, Fingolimod Improves MRI Outcomes of Pediatric MS
NASHVILLE—In patients with pediatric-onset multiple sclerosis (MS), fingolimod significantly reduces MRI activity and slows brain volume loss for...
Conference Coverage
Can Exercise Improve Vision in Children With MS?
NASHVILLE—Moderate-to-vigorous physical activity is positively associated with retinal nerve fiber layer thickness in children...
Conference Coverage
More Frequent Dosing of Interferon Beta-1a May Benefit Patients With MS With Breakthrough Disease
NASHVILLE—Patients with multiple sclerosis (MS) with breakthrough disease may benefit from intramuscular interferon beta 1-a treatment twice per...
Conference Coverage
Ocrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label Extension
NASHVILLE—The benefits of ocrelizumab on 24-week confirmed disability improvement, which were demonstrated in two-year, double-...
Video
Global MS trends: A chaotic picture with risk as the central theme
It’s tough to draw firm conclusions from the vastly varied studies assessing epidemiologic patterns of MS around the world, says Dr. Alberto...
Video
Focus on preventing comorbidities in MS, physician urges
NASHVILLE, TENN. – It’s a kind of ‘lifestyle disease’ since other conditions can worsen it, Dr. Allen C. Bowling says, so healthier living is...
Video
New guidelines for gadolinium-based contrast agents take conservative stance
NASHVILLE, TENN. – The agents remain necessary in initial diagnosis and other specific clinical scenarios.
Conference Coverage
-
-
-
-
-
Multimedia
Question 1 of 5